Trademark applications and grants for Eisai Inc. Eisai Inc has 139 trademark applications. The latest application filed is for "ADLI"
Patent Application | Date |
---|---|
CHLOROTOXIN AGENTS AND USES THEREOF 20200206312 - 16/646998 McGonigle; Sharon ;   et al. | 2020-07-02 |
METHODS FOR TREATMENT OF OVARIAN CANCER 20190202930 - 16/357577 SCHWEIZER; Charles ;   et al. | 2019-07-04 |
PROGNOSIS OF SEROUS OVARIAN CANCER USING BIOMARKERS 20190064172 - 16/093180 O'SHANNESSY; Daniel John | 2019-02-28 |
ERIBULIN-BASED ANTIBODY-DRUG CONJUGATES AND METHODS OF USE 20170252458 - 15/448497 Albone; Earl F ;   et al. | 2017-09-07 |
PARP INHIBITOR COMPOUNDS, COMPOSITIONS AND METHODS OF USE 20150141429 - 14/538447 XU; Weizheng ;   et al. | 2015-05-21 |
NCAGE Code | 6MLQ1 | EISAI INC. |
CAGE Code | 6MLQ1 | EISAI INC. |
S.A.M. Registration | 6MLQ1 [189246791] | EISAI INC. |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.